RSSCategory: Community

MSD launches new manufacturing facilities in Singapore

October 7, 2022
MSD (trade name of Merck & Co., Inc.) has opened a new secondary packaging facility in Singapore, the home of MSD’s Asia Pacific hub. The secondary packaging facility is expected to support the production of vaccines and biologics, including the company’s cancer immunotherapy products. MSD also broke ground for a new inhaler production facility for the manufacture of new generation inhaler medicines in Singapore. Both manufacturing facilities are key components of the company’s up to US$500 million investment over five years that started in 2020 – in addition to the US$2 billion invested since the start of MSD’s manufacturing operations in Singapore in 1997. Other components of the US$500 million investment include incorporation of new technology to further MSD’s environmental sustainability goals, and modernisation of MSD’s information technology (IT) infrastructure in support of digitising the facilities. The opening of the new secondary packaging facility and ground-breaking for the inhaler production facility was witnessed by Singapore’s Minister for Trade & Industry and Guest-of-Honour, Gan Kim Yong, and Robert Davis, CEO and President of MSD. The new facilities are located within MSD’s existing 72-acre, multi-product manufacturing hub in Tuas. The secondary packaging facility will house a semi-automated, vial-packaging line to produce immunotherapy drug Keytruda (pembrolizumab), and three fully automated syringe-packaging lines to produce the company’s HPV recombinant vaccine, Gardasil. In 2021, the site commenced the sterile filling process of the immunotherapy drug vials. Secondary packaging, cold storage, and a quality control laboratory will be a part of the expanded facility which further adds to the supply chain footprint for this product in Singapore. Meanwhile, the new inhaler medicine facility, when ready in 2026, will manufacture next generation inhaler devices for targeted administration of medicines. “MSD is committed to Singapore as a strategic node in our company’s global manufacturing network with a focus on producing innovative medicines to treat chronic diseases and cancer as well as vaccines that prevent infectious diseases for patients living in Singapore and throughout the Asia Pacific region and beyond,” said Fernando Otero, Associate VP, MSD Manufacturing Division, Singapore. “The talent, research, and technology capabilities that first attracted our company to Singapore has been a key incentive for our continuing investment. We’re delighted to further invest in building technologically advanced facilities and highly skilled manufacturing here,” he added. The multi-year investment plan is estimated to create over 100 new jobs over the next few years to support the new facility, with many positions requiring advanced manufacturing and digital skills. This would bring the company’s total employees in Singapore to more than 1,800 over the next few years. In a closing note, David Peacock, President, Asia Pacific, MSD, said, “MSD has been in Singapore since 1993 and continues to invest significantly in Singapore to impact patients worldwide through our innovative medicines and vaccines. “The launch of the new secondary packaging facility and ground-breaking for the new inhaler facility today highlights the value that biopharmaceutical innovation brings to Singapore, contributing to the health and wellbeing of the nation and the region. It further demonstrates our commitment to making a difference by bringing our medicines and vaccines to people as quickly as possible, while ensuring that the Asia Pacific region is well-positioned to manage future healthcare challenges.”

MSD (trade name of Merck & Co., Inc.) has opened a new secondary packaging facility in Singapore, the home of MSD’s Asia Pacific hub. The secondary packaging facility is expected to support the production of vaccines and biologics, including the […]

Continue Reading

Treasure hunt fundraiser activity for the National Kidney Foundation of Malaysia

September 29, 2022

Sunway Medical Centre Velocity (SMCV) recently held a treasure hunt event in conjunction with its third anniversary, to raise funds for the National Kidney Foundation of Malaysia (NKF).  All funds obtained were channelled to the NKF to raise awareness of […]

Continue Reading

Businesses partner to ease patients’ access to therapeutic products for dermatology, in Asia 

September 29, 2022

Healthcare companies DKSH Business Unit Healthcare (DKSH) and LEO Pharma have entered into an agreement to bring high-quality therapeutic products for dermatology and thrombosis to patients across Asia – partnering in Hong Kong, Malaysia, Singapore, Taiwan, Thailand, Vietnam, and the […]

Continue Reading

“Listen To Your Asthma” campaign launched by AstraZeneca and Asthma Malaysia

September 27, 2022

Biopharmaceutical group AstraZeneca (AZ) has launched an asthma awareness campaign entitled, “Listen To Your Asthma,” to help educate and raise awareness about severe asthma so that those suffering from severe asthma symptoms can get the right diagnosis and treatment to […]

Continue Reading

How you can reduce your risk of silent heart attacks

September 26, 2022

Silent heart attacks, known as silent myocardial infarction (SMI), account for 45% of heart attacks. They are described as “silent” because they occur without the usual, recognisable symptoms of a heart attack; but can still lead to a myriad of […]

Continue Reading

Virus to kill cancer cells trialled in UK

September 26, 2022

A new type of cancer therapy that uses a common virus to infect and destroy harmful cells is showing big promise in early human trials, say UK scientists. One patient’s cancer vanished, while others saw their tumours shrink. The drug […]

Continue Reading

Free lung cancer screening for Malaysians at select private cancer facilities

September 23, 2022

The public will soon be able to access cutting-edge Artificial Intelligence (AI) screening technology for lung cancer detection at three primary care clinics: Beacon Hospital, Subang Jaya Medical Centre and Sunway Medical Centre. The free AI-lung cancer screening programme was […]

Continue Reading

Two COVID antibody treatments no longer recommended by WHO

September 19, 2022

The World Health Organisation (WHO) “strongly advises against” the use of two COVID-19 antibody therapies developed during the early days of the pandemic, citing mounting evidence that the virus’ continued evolution has rendered the two therapies obsolete. The two therapies, […]

Continue Reading

The health consequences short girls face

September 19, 2022

For girls, being short or petite is often considered cute and comely – but according to Associate Professor Dr. Azriyanti binti Anuar Zaini, Consultant Paediatrician and Paediatric Endocrinologist; and Associate Professor in the Department of Paediatrics, Faculty of Medicine, University […]

Continue Reading

World Alzheimer’s Month: Coping with Alzheimer’s and dementia

September 16, 2022

The memory loss typical of Alzheimer’s disease (Alzheimer’s) and dementia is often misunderstood to be a consequence of aging. In conjunction with World Alzheimer’s Month this September, it’s time for us to better understand the differences between Alzheimer’s and dementia, […]

Continue Reading